Decreased expression of the glucocorticoid receptor-GILZ pathway in Kupffer cells promotes liver inflammation in obese mice

Journal of Hepatology

Volumn 64, Issue 4, 2016, Pages 916-924

  Robert, Olivier ^a,b   Boujedidi, Hédia ^a,b   Bigorgne, Amélie ^a,b   Ferrere, Gladys ^a,b   Voican, Cosmin Sebastian ^c   Vettorazzi, Sabine ^d   Tuckermann, Jan Peter ^d   Bouchet Delbos, Laurence ^a   Tran, Thi ^a   Hemon, Patrice ^a   Puchois, Virginie ^a,b   Dagher, Ibrahim ^b,c   Douard, Richard ^e,f   Gaudin, Francoise ^a,g   Gary Gouy, Hélène ^g   Capel, Francis ^a   Durand Gasselin, Ingrid ^a   Prévot, Sophie ^c   Rousset, Sophie ^a   Naveau, Sylvie ^c   Godot, Véronique ^a,b   Emilie, Dominique ^a,b   Lombès, Marc ^b,c,h,i   Perlemuter, Gabriel ^a,b,c   Cassard, Anne Marie ^a,b   more..

^a Universite Paris Sud   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d UNIVERSITY OF ULM   (Germany)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f AVICENNE HOSPITAL   (France)

^g IPSIT   (France)

^h INSERM   (France)

ⁱ BICÊTRE HOSPITAL   (France)

Author keywords

Glucocorticoid receptor; Glucocorticoid induced leucine zipper; Inflammation; Kupffer cells; Liver; Obesity

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID INDUCED LEUCINE ZIPPER PROTEIN; GLUCOCORTICOID RECEPTOR; LEUCINE ZIPPER PROTEIN; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; DSIP1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HEPATITIS; KUPFFER CELL; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL CULTURE; COMPLICATION; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; DEXAMETHASONE; HEPATITIS; KUPFFER CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION FACTORS;

EID: 84961879961     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.11.023     Document Type: Article

References (54)

1. G. Perlemuter, A. Bigorgne, A.M. Cassard-Doulcier, and S. Naveau Nonalcoholic fatty liver disease: from pathogenesis to patient care Nat Clin Pract Endocrinol Metab 3 2007 458 469
2. G. Baffy Kupffer cells in non-alcoholic fatty liver disease: the emerging view J Hepatol 51 2009 212 223
3. L. Miele, V. Valenza, G. La Torre, M. Montalto, G. Cammarota, R. Ricci, and et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease Hepatology 49 2009 1877 1887
4. A. Leroux, G. Ferrere, V. Godie, F. Cailleux, M.L. Renoud, F. Gaudin, and et al. Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis J Hepatol 57 2012 141 149
5. Y.J. Wan, M. Morimoto, R.G. Thurman, H.K. Bojes, and S.W. French Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease Life Sci 56 1995 307 317
6. J.I. Odegaard, R.R. Ricardo-Gonzalez, A. Red Eagle, D. Vats, C.R. Morel, M.H. Goforth, and et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance Cell Metab 7 2008 496 507
7. A.E. Bigorgne, L. Bouchet-Delbos, S. Naveau, I. Dagher, S. Prevot, I. Durand-Gasselin, and et al. Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice Gastroenterology 134 2008 1459 1469
8. F. D'Adamio, O. Zollo, R. Moraca, E. Ayroldi, S. Bruscoli, A. Bartoli, and et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death Immunity 7 1997 803 812
9. D. Berrebi, S. Bruscoli, N. Cohen, A. Foussat, G. Migliorati, L. Bouchet-Delbos, and et al. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10 Blood 101 2003 729 738
10. H. Hamdi, A. Bigorgne, S. Naveau, A. Balian, L. Bouchet-Delbos, A.M. Cassard-Doulcier, and et al. Glucocorticoid-induced leucine zipper: a key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis Hepatology 46 2007 1986 1992
11. E. Ayroldi, G. Migliorati, S. Bruscoli, C. Marchetti, O. Zollo, L. Cannarile, and et al. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB Blood 98 2001 743 753
12. P.R. Mittelstadt, and J.D. Ashwell Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ J Biol Chem 276 2001 29603 29610
13. P.J. Gough, S. Gordon, and D.R. Greaves The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo Immunology 103 2001 351 361
14. A. Kleiman, S. Hubner, J.M. Rodriguez Parkitna, A. Neumann, S. Hofer, M.A. Weigand, and et al. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages FASEB J 26 2012 722 729
15. L. Martinerie, S. Viengchareun, A.L. Delezoide, F. Jaubert, M. Sinico, S. Prevot, and et al. Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates Endocrinology 150 2009 4414 4424
16. M.L. Asselin-Labat, M. David, A. Biola-Vidamment, D. Lecoeuche, M.C. Zennaro, J. Bertoglio, and et al. GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis Blood 104 2004 215 223
17. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, O.W. Cummings, and et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
18. J.C. Wang, M.K. Derynck, D.F. Nonaka, D.B. Khodabakhsh, C. Haqq, and K.R. Yamamoto Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes Proc Natl Acad Sci U S A 101 2004 15603 15608
19. G.W. Strain, B. Zumoff, J.J. Strain, J. Levin, and D.K. Fukushima Cortisol production in obesity Metabolism 29 1980 980 985
20. S.A. Lottenberg, D. Giannella-Neto, H. Derendorf, M. Rocha, A. Bosco, S.V. Carvalho, and et al. Effect of fat distribution on the pharmacokinetics of cortisol in obesity Int J Clin Pharmacol Ther 36 1998 501 505
21. P.M. Stewart Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome-11beta-hydroxysteroid dehydrogenase type 1 Clin Med 5 2005 142 146
22. P.M. Stewart, J.E. Corrie, C.H. Shackleton, and C.R. Edwards Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle J Clin Invest 82 1988 340 349
23. C.R. Edwards, P.M. Stewart, D. Burt, L. Brett, M.A. McIntyre, W.S. Sutanto, and et al. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor Lancet 2 1988 986 989
24. A. Stomby, R. Andrew, B.R. Walker, and T. Olsson Tissue-specific dysregulation of cortisol regeneration by 11betaHSD1 in obesity: has it promised too much? Diabetologia 57 2014 1100 1110
25. T. Rhen, and J.A. Cidlowski Antiinflammatory action of glucocorticoids-new mechanisms for old drugs N Engl J Med 353 2005 1711 1723
26. P.M. Stewart, A. Boulton, S. Kumar, P.M. Clark, and C.H. Shackleton Cortisol metabolism in human obesity: impaired cortisone->cortisol conversion in subjects with central adiposity J Clin Endocrinol Metab 84 1999 1022 1027
27. G. Valsamakis, A. Anwar, J.W. Tomlinson, C.H. Shackleton, P.G. McTernan, R. Chetty, and et al. 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus J Clin Endocrinol Metab 89 2004 4755 4761
28. M.L. Asselin-Labat, A. Biola-Vidamment, S. Kerbrat, M. Lombes, J. Bertoglio, and M. Pallardy FoxO3 mediates antagonistic effects of glucocorticoids and interleukin-2 on glucocorticoid-induced leucine zipper expression Mol Endocrinol 19 2005 1752 1764
29. N.A. Rao, M.T. McCalman, P. Moulos, K.J. Francoijs, A. Chatziioannou, F.N. Kolisis, and et al. Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes Gen Res 21 2011 1404 1416
30. C. Jonat, H.J. Rahmsdorf, K.K. Park, A.C. Cato, S. Gebel, H. Ponta, and et al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone Cell 62 1990 1189 1204
31. J. Eddleston, J. Herschbach, A.L. Wagelie-Steffen, S.C. Christiansen, and B.L. Zuraw The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells J Allergy Clin Immunol 119 2007 115 122
32. Y.H. Yang, D. Aeberli, A. Dacumos, J.R. Xue, and E.F. Morand Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper J Immunol 183 2009 1435 1445
33. N. Yang, W. Zhang, and X.M. Shi Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression J Cell Biochem 103 2008 1760 1771
34. J. Hoppstadter, S.M. Kessler, S. Bruscoli, H. Huwer, C. Riccardi, and A.K. Kiemer Glucocorticoid-induced leucine zipper: a critical factor in macrophage endotoxin tolerance J Immunol 194 2015 6057 6067
35. L. Cannarile, S. Cuzzocrea, L. Santucci, M. Agostini, E. Mazzon, E. Esposito, and et al. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis Gastroenterology 136 2009 530 541
36. E. Beaulieu, D. Ngo, L. Santos, Y.H. Yang, M. Smith, C. Jorgensen, and et al. Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis Arthritis Rheum 62 2010 2651 2661
37. R.T. Hahn, J. Hoppstadter, K. Hirschfelder, N. Hachenthal, B. Diesel, S.M. Kessler, and et al. Downregulation of the glucocorticoid-induced leucine zipper (GILZ) promotes vascular inflammation Atherosclerosis 234 2014 391 400
38. R. Krzysiek Role of glucocorticoid-induced leucine zipper (GILZ) expression by dendritic cells in tolerance induction Transplant Proc 42 2010 3331 3332
39. I.N. Crispe, M. Giannandrea, I. Klein, B. John, B. Sampson, and S. Wuensch Cellular and molecular mechanisms of liver tolerance Immunol Rev 213 2006 101 118
40. H.J. Tsai, and D.R. Romsos Glucocorticoid and mineralocorticoid receptor-binding characteristics in obese (ob/ob) mice Am J Physiol 261 1991 E495 E499
41. M. Kinoshita, T. Uchida, A. Sato, M. Nakashima, H. Nakashima, S. Shono, and et al. Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice J Hepatol 53 2010 903 910
42. H. Nakashima, Y. Ogawa, S. Shono, M. Kinoshita, M. Nakashima, A. Sato, and et al. Activation of CD11b+ Kupffer cells/macrophages as a common cause for exacerbation of TNF/Fas-ligand-dependent hepatitis in hypercholesterolemic mice PLoS One 8 2013 e49339
43. M. Ikarashi, H. Nakashima, M. Kinoshita, A. Sato, M. Nakashima, H. Miyazaki, and et al. Distinct development and functions of resident and recruited liver Kupffer cells/macrophages J Leukoc Biol 94 2013 1325 1336
44. E. Gomez Perdiguero, K. Klapproth, C. Schulz, K. Busch, E. Azzoni, L. Crozet, and et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors Nature 518 2015 547 551
45. D. Hashimoto, A. Chow, C. Noizat, P. Teo, M.B. Beasley, M. Leboeuf, and et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes Immunity 38 2013 792 804
46. C. Schulz, E. Gomez Perdiguero, L. Chorro, H. Szabo-Rogers, N. Cagnard, K. Kierdorf, and et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells Science 336 2012 86 90
47. M. Noti, N. Corazza, G. Tuffin, K. Schoonjans, and T. Brunner Lipopolysaccharide induces intestinal glucocorticoid synthesis in a TNFalpha-dependent manner FASEB J 24 2010 1340 1346
48. C.A. Salkowski, and S.N. Vogel Lipopolysaccharide increases glucocorticoid receptor expression in murine macrophages. A possible mechanism for glucocorticoid-mediated suppression of endotoxicity J Immunol 149 1992 4041 4047
49. L. Dejager, I. Pinheiro, L. Puimege, Y.D. Fan, L. Gremeaux, H. Vankelecom, and et al. Increased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice J Biol Chem 285 2010 31073 31086
50. S. Bhattacharyya, D.E. Brown, J.A. Brewer, S.K. Vogt, and L.J. Muglia Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase Blood 109 2007 4313 4319
51. K. Cusi Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications Gastroenterology 142 2012 e716
52. C.F. Nitta, and R.A. Orlando Crosstalk between immune cells and adipocytes requires both paracrine factors and cell contact to modify cytokine secretion PLoS One 8 2013 e77306
53. U. Kintscher, M. Hartge, K. Hess, A. Foryst-Ludwig, M. Clemenz, M. Wabitsch, and et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance Arterioscler Thromb Vasc Biol 28 2008 1304 1310
54. A. Hirata, N. Maeda, H. Nakatsuji, A. Hiuge-Shimizu, T. Okada, T. Funahashi, and et al. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction Biochem Biophys Res Com 419 2012 182 187